Genetic Variant Boosts Risk of GVHD in Allogeneic Transplants

According to a new study published in the New England Journal of Medicine, the risk of developing graft versus host disease (GVHD) following an allogeneic stem cell transplant is significantly increased in patients with a specific genetic variant.

The genetic variant is associated with increased expression of the HLA-DPB1 gene.

Specifically, patients who are found through genotyping to have the high-expression rs9277534G allele are at a 54 percent greater risk of developing GVHD following HLA-mismatched transplants compared with patients who have the corresponding low-expression rs9277534A allele.

Furthermore, the risk of death from causes other than disease recurrence was found to be 25 percent higher in patients undergoing transplants who have the high-expression allele.

“Our data provide new information on the role of HLA-DPB1 expression in transplantation associated risks that can be used to guide the selection of donors for future transplant recipients in order to minimize the risk of acute GVHD," concluded Effie Petersdorf MD of Fred Hutchinson Cancer Research Center in Seattle and co-authors. "We discovered that if rs9733534 genotypes had been known at the time of the search for an unrelated donor, almost 55% of recipients with rs9277534AG would have had suitable donors, and mismatching for their G-linked HLA-DPB1 allele could have been avoided."

The research team also concluded that the donors of choice for patients receiving an allogeneic transplant remain fully HLA-matched donors with the high-expression allele, and that they believed their study supported genotyping for both rs9277534 and HLA-DPB1 in the donor selection process.

Source: MedPage Today

More Articles

More Articles

Lymphoma patients may have the option to participate in clinical trials, gaining access to an experimental treatment before it is widely available...

Since there are several subtypes of T cell lymphoma, there will necessarily be several non-specific T cell lymphoma...

In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...

After surviving lymphoma treatments, patients should be on the lookout for late effects. These are symptoms that arise well after treatment has...

Canine lymphoma is a fairly common cancer in American dogs. The most commonly seen lymphoma in America is a type called Lymphosarcoma, although...

Advances in the treatment of Hodgkin's lymphoma have resulted in remarkable survival rates, even for...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...

The short answer: both. Let's begin with a simple definition of radiation: Radiation is the energy emitted from an energy source. That energy...

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

When you consider that the adult human body has anywhere from 300 to 700 lymph nodes, the better question might not be where ARE they located, but...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Intravascular lymphoma is a subtype of 'Lymphoma', an umbrella term that loosely refers to several dozen...